IL17A and interstitial lung disease: In a zymosan-induced model of interstitial lung disease associated with arthritis development, GM-CSF blockade in SKG mice prevented and ameliorated lung and joint inflammation, while IL-17A blockade had only a minor effect on disease severity64.